ICM
BVS icon

Islay Capital Management’s Bioventus BVS Stock Holding History

Islay Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$28.9K – 223
2023
Q2 		$28.9K Sell
10,000
-20,000
-67% -$38.4K 0.03% 147
2023
Q1 		$32.1K Buy
+30,000
New +$57.4K 0.03% 148

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Islay Capital Management's BVS Position: Q3 2023 in Review

Islay Capital Management sold out of Bioventus (BVS) in Q3 2023, closing a stake of 10,000 shares — an estimated $28.9K sold.

Islay Capital Management first reported a position in BVS in Q1 2023 and held it in 2 quarters. The position peaked at $32.1K in Q1 2023. 67 funds tracked by Wall St. Rank hold BVS as of Q3 2023.

  • Islay Capital Management reported no remaining Bioventus position as of Q3 2023 after selling out during the quarter.
  • Islay Capital Management sold 10,000 Bioventus shares in Q3 2023, an estimated $28.9K.
  • Islay Capital Management first reported a position in Bioventus in Q1 2023 and held it in 2 quarters.
  • Islay Capital Management's Bioventus position peaked at $32.1K in Q1 2023.
  • 67 funds tracked by Wall St. Rank held Bioventus as of Q3 2023.

Based on Islay Capital Management's 13F filing for Q3 2023, filed 2 Nov 2023.